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Abstract The aim was to retrospectively analyse the
clinical–histopathological characteristics of patients with
newly diagnosis of differentiated thyroid cancer (DTC)
referred to two Italian centres, one in Northern and the
other in Southern Italy, between 2000 and 2013. 1081
patients were included and subdivided into two groups:
group A (474 patients from Novara) and group B (607
patients from Naples). The group A came from the indus-
trial area of Novara, while the Group B came from the
areas around Vesuvius and Campi Flegrei. The two groups
were comparable for iodine levels, body mass index,
diagnostic timing and clinical procedures. For all patients,
demographic and clinical data were collected. No differ-
ence was found in gender, whereas the age at diagnosis was
later in the group A (group A 53.1 ± 15.16 years, group B
41.9 ± 14.25 years, p\ 0.001). In both groups, the most
frequent histotype was papillary thyroid cancer (PTC) with
prevalence of follicular variant in group A (p\ 0.0001)
and classical variant in group B (p\ 0.0001). Aggressive
histological features were mainly seen in group A (bilat-
erality p\ 0.0001, multifocality p\ 0.0001 and thyroid
capsular invasion p\ 0.0001). Microcarcinomas were
more frequent in group A (p\ 0.0001) but mostly
characterized by bilaterality (p\ 0.001) and multifocality
(p\ 0.04). In both groups, tumour-associated thyroiditis
showed a significant increase over the years (group A
p\ 0.05, group B p\ 0.04). Environmental factors could
justify the differences found in our study. These prelimi-
nary data should stimulate the need for an Italian Cancer
Registry of DTC in order to allow an epidemiological
characterization, allowing the identification of specific
etiological factors and an improvement in the management
of the disease.
Keywords Thyroid cancer  Tumourigenesis induction 
Clinical–histopathological features  Environmental factors
Introduction
The incidence of the differentiated thyroid carcinoma
(DTC) has been increasing in many countries over the last
30 years [1–11].
The most recent data about this massive increase in the
incidence come from the U.S. SEER (Surveillance, Epi-
demiology, and End Results) which shows that the age-
adjusted incidence rate has increased from 4.85/100,000/
year in 1975 to 14.93/100,000/year in 2011 [1].
In Italy, a marked increase occurred over the last three
decades, both in men (?9.1 % per year) and in women
(?8.7 % per year), according to AIRTUM (Italian Asso-
ciation of Cancer Registries), AIOM data (Italian Associ-
ation of Medical Oncology) and literature [11]; in
particular, more than 16,000 new cases were seen in 2013
(4100 men and 12,200 women), representing about 4.5 %
of all new cases [12].
The reported incidence increase in all countries is
almost exclusively due to an increase in the papillary
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thyroid carcinomas variant (PTC), with no significant
changes in the follicular (FTC), medullary and anaplastic
form [2]. Despite the most part of PTC consists in indolent
micro/small carcinomas [2], the mortality rate has not
decreased, standing around 0.5 per 100,000 per year in both
sexes in almost all countries [13, 14].
Therefore, even if the increased incidence could be
attributed to a better diagnostic accuracy [11, 15, 16], we
cannot exclude environmental and lifestyle causative fac-
tors [17–19].
Major data about epidemiology and risk factors for DTC
come from geographical areas, such as United States,
where the vastness, the presence of different ethnic groups
and different lifestyles make difficult to evaluate the
environmental carcinogens [2, 4–6]. In Italy, this limit
could be avoided thanks to the territorial limited extension,
the more homogeneous population and the comparable
lifestyle in all regions [20–23].
The aim of our study was to retrospectively analyse the
clinical and histopathological characteristics of Italian
caucasic patients with DTC referred to two Italian centres,
the University Hospital (AOU) ‘‘Maggiore della Carita`’’ in
Novara, in Northern Italy and the University Hospital
(AOU), Federico II in Naples, in Southern Italy, in order to
evaluate the possible differences of DTC in these popula-
tions compared to data reported in the national literature.
Patients and methods
We retrospectively analysed clinical and pathological fea-
tures of patients with newly diagnosis of DTC referred to 2
clinical centres: ‘‘Maggiore della Carita`’’ University
Hospital (Novara) in Northern Italy and ‘‘Federico II’’
University Hospital (Naples) in Southern Italy, from Jan-
uary 2000 to December 2013. All cases were collected
from the Pathology archive of each centre.
Patients were subdivided into two groups, according to
the centre of origin (Group A = Novara; Group
B = Naples).
The group A patients came from the eastern province of
Novara, a typical industrial area, while the Group B pop-
ulation came from the areas around the volcano Vesuvius
and Campi Flegrei, an active sunken volcanic area.
According to ARPA (Regional Agency for Environ-
mental Protection) data, there are some differences in
exposure between these two Italian regions: Novara pop-
ulation is exposed to industrial chemicals, such as
formaldehyde and benzene [24], while Naples area is
exposed to minerals of volcanic origin such as nitrates,
vanadium, manganese and other heavy metals [25].
The two groups were comparable for iodine levels, body
mass index (BMI), diagnostic timing and clinical
procedures.
Patients data were collected through retrospective
medical record review regarding demographics and clinical
aspects (age, gender, BMI, ioduria, type of surgery) and
histological reports including information about tumour
size, extrathyroidal extension, multifocality, lymph-nodal
(LN) metastasis and presence of peritumoural thyroiditis.
Environmental and occupational exposures were iden-
tified through a direct interview for each patient. Smoking
habits, hormonal and genetic factors were not investigated
because the evaluation of this clinical outcome was not a
purpose of the study.
Patients with history of medical irradiation, poorly dif-
ferentiated, anaplastic, medullary thyroid carcinomas and
secondary tumours or living for less than 5 years in the
analysed areas were excluded.
Our data relating to ioduria were extrapolated from a
new document, which contains information about ioduria
in 16 Italian regions including Piedmont and Campania.
This document was published by Italian ‘‘Istituto Superiore
di Sanita`’’ in 2014 [26].
Histological diagnoses were blindly determined by two
independent pathologists, specialized in thyroid pathology,
belonging to the two centres. Pathologic staging was
redefined according to the Tumour, Lymph Node, and
Metastasis classification system based on the 6th edition of
the UICC/AJCC TNM classification [27].
Moreover, we evaluated the frequency and histopatho-
logical characteristics of microcarcinomas (defined as
tumours 1 cm or less in size [28]) in both the groups.
For all cases, tumour-associated thyroiditis was asses-
sed. The histological criteria used to make this diagnosis
included diffuse lymphoplasmacytic infiltration, germinal
centres and enlarged epithelial cells with large nuclei and
eosinophilic cytoplasm (Hurthle cells), which are specific
for Hashimoto’s thyroiditis (HT) and also polynuclear
macrophage-like and fibroblastic-like population specific
for non-specific lymphocytic thyroiditis, which might
represent perineoplastic inflammation, when occurring
immediately adjacent to a tumour [29].
The results were expressed as mean ± standard devia-
tion (SD) or percentage with 95 % confidence intervals.
The association between factors was assessed with the
multinomial logistic regression for dichotomous or cate-
gorical variables. Continuous variables were analysed
using student t test.
P values less than 0.05 were considered significant. The
analyses were performed using SPSS 17.0 (SPSS Inc.,
Chicago, Ill., USA).
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Results
1081 patients were included in this study: group A = 474
patients and group B = 607 patients.
The clinical and histopathological characteristics of all
patients are reported in Table 1.
Group A (474 cases)
In this population, the majority of patients were female
(76.4 %) with a M:F ratio of 1:3. The mean age at diag-
nosis (mean ± SD) was 53.1 ± 15.16 years (range:
13.0–88.0 years); in particular, 68.6 % was aged
Table 1 Clinical and histopathological characteristics of all patients divided into two study groups: group A (Novara) and group B (Naples)
GROUP A (NOVARA)
(474 CASES)
GROUP B (NAPLES)
(607 CASES)
Age at diagnosis \45 years (%) 31.4 58.3
C45 years (%) 68.6 41.7
Mean ± SD (years) 53.1 ± 15.16 41.9 ± 14.28
Gender Male (%) 23.6 22.2
Female (%) 76.4 77.8
Body Mass Index Mean ± SD (Kg/m2) 26.6 ± 4.52 27.1 ± 5.57
Type of surgery Total or near total thyroidectomy (%) 99.2 99.7
Lobectomy (%) 0.8 0.3
Lymphadenectomy No (%) 71.9 53.1
Yes (%) 28.1 46.9
Histotype PTC (%) 90.0 89.0
FTC (%) 9.0 11.0
PTC ? FTC (%) 1.0 0.0
PTC variant Classic (%) 36.9 63.8
Follicular (%) 37.3 19.9
Classic and Follicular (%) 9.1 7.6
Other (%) 16.7 8.7
Size \1.0 cm (%) 44.1 30.4
2.0 cm (%) 27.8 43.9
2.0–4.0 cm (%) 22.6 21.9
[4.0 cm (%) 5.5 3.8
Multifocality Absent (%) 68.8 78.9
Present (%) 31.2 21.1
Bilaterality Absent (%) 74.7 86.8
Present (%) 25.3 13.2
Capsular Invasion Absent (%) 80.8 91.3
Present (%) 19.2 8.7
Staging
(TNM 2010)
Stage I (%) 75.3 88.4
Stage II (%) 8.9 5.5
Stage III (%) 11.4 4.1
Stage IV (%) 4.4 2.0
Histological associated thyroiditis Absent (%) 75.5 70.3
Present (%) 24.5 29.7
Lymph Node Metastasis Absent (%) 49.2 49.8
Present (%) 50.8 50.2
TPOAba Absent (%) 70.0 67.0
Present (%) 30.0 33.0
a TPOAb assays has a functional sensitivity of 25.0 U/mL and the analysis was automatically performed using ‘‘ADVIA Centaur ATPO’’
(Siemens Healthcare Diagnostic inc., Tarrytown, NY, USA)
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[45 years. The mean BMI (mean ± SD) was
26.6 ± 4.52 kg/m2.
Total thyroidectomy was performed in 99.2 % of cases
and 28.1 % of patients also underwent lymphadenectomy.
The most frequent histotype was PTC (90.0 %), and the
most widespread variant was the follicular one (37.3 % of
all PTCs), followed by the classical variant (36.9 %). FTC
was detected in 9.0 % of cases. Only 5.5 % of tumours
were sized [4.0 cm, while microcarcinomas represented
the majority of cases (44.1 %).
The 75.3 % of tumours were classified as stage I, fol-
lowed by stage III tumours (11.4 %), with high frequency
of thyroid capsular invasion (19.2 %). Tumours were
bilateral in the 25.3 % of cases and multifocal in the
31.2 % of cases. Among patients who underwent lym-
phadenectomy, 50.8 % had lymph node metastasis.
Finally, tumour-associated thyroiditis was histologically
found in 24.5 % of cases.
Group B (607 cases)
In this group, the disease was more frequent in females
with M:F ratio of 1:3.
The mean age at diagnosis (mean ± SD) was
41.9 ± 14.28 years (range: 8.0-84.0 years); in particular,
58.3 % of the patients were aged \45 years. The mean
BMI (mean ± SD) was 27.1 ± 5.57 kg/m2.
99.7 % of patients underwent total thyroidectomy with
lymphadenectomy in 46.9 % of cases.
The most frequent histotype was PTC (89.0 %), and the
most widespread variant was the classical (63.8 % of total
PTCs), followed by follicular (19.9 %). The 11.0 % of
patients was affected by FTC.
Tumours sized [1.0 cm and \2.0 cm represented the
majority of cases (43.9 % of cases).
Stage I tumours represented more than three-quarters of
the cases (88.4 %), followed by stage II (5.5 %), stage III
(4.1 %) and stage IV (2.0 %) tumours.
Tumours were bilateral in 13.2 % of cases and multi-
focal in 21.1 % of cases, and the thyroid capsular invasion
was found only in 8.7 % of cases. Among patients who
underwent lymphadenectomy, 50.2 % had lymph node
metastasis.
Finally, the tumour-associated thyroiditis was histolog-
ically found in 29.7 % of cases.
Group A vs Group B
With regard to the clinical characteristics, the age at
diagnosis was earlier in group B than in group A
(p\ 0.001) (Fig. 1).
Moreover, no significant difference was found in BMI
(26.6 ± 4.52 kg/m2 in group A and 27.1 ± 5.57 kg/m2 in
group B).
In both populations, we observed an upward trend over
time of PTC cases (Fig. 2).
Regarding histotype, the most frequent was PTC in both
the groups; the follicular variant was more represented in
group A, while the classical variant in group B
(p\ 0.0001) (Fig. 3). Furthermore, most aggressive vari-
ants were observed more in group A than in group B,
although without statistical significance. Histopathological
differences were found between the two populations:
bilaterality (group A vs. group B, 25.3 % vs. 13.2 %,
p\ 0.0001), multifocality (group A vs. group B, 31.2 %
vs. 21.1 %, p\ 0.0001) and thyroid capsular invasion
(group A vs. group B, 19.2 % vs. 8.7 %, p\ 0.0001)
(Fig. 4).
Regarding smaller tumours, microcarcinomas were sig-
nificantly more frequent in group A (p\ 0.0001) with
respect to group B, and, similarly to macroscopic tumours,
in Novara’s group they were mostly characterized by
bilaterality (group A vs. group B, 20.5 % vs. 8.3 %,
p\ 0.001), multifocality (group A vs. group B, 25.9 % vs.
16.6 %, p\ 0.04) and, without reaching significance,
Fig. 1 Age at diagnosis in groups A and B
Fig. 2 PTC and FTC in groups A and B: trend over the years
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thyroid capsular invasion (group A vs. group B, 6.3 % vs.
4.1 %).
Therefore, stage I tumours were more represented in
group B than in group A (p\ 0.0001), considering the
earliest age of discovery of the disease (Fig. 5).
With regard to the presence of lymph node metastasis
(N) and distance metastasis (M) at the time of diagnosis, no
difference was found between the two groups, nor about
the presence of thyroiditis, considering both thyroid per-
oxidase antibodies (TPOAb) positivity and the presence of
lymphocytic and non-specific lymphocytic peritumoral
inflammation; however, this tumour-associated thyroiditis
showed a significant progressive increase over the years, in
both the populations (p\ 0.05 in group A, p\ 0.04 in
group B) (Fig. 6).
Discussion
The study of clinical, histopathological and epidemiologi-
cal characteristics directly influences diagnostic and ther-
apeutic decisions in the field of oncology [30].
In recent years, the literature reported a significant
increase in the incidence of PTC worldwide and in par-
ticular in Italy [1–11].
In our study, we observed the same upward trend in
incidence of thyroid cancer cases in both the cohorts
studied; however, considering the clinical and histopatho-
logical characteristics at the time of diagnosis, some dif-
ferences emerge, leading to hypothesize that environmental
and carcinogens factors could change the DTC
tumourigenesis.
First, we observed a difference in age at diagnosis
between the two populations. In fact, in the Neapolitan
population, thyroid cancer seems to be diagnosed earlier
than in Novara population, in agreement with other
national and international studies reported in literature [11,
31]. Interestingly, in group B, we observed a high per-
centage of subjects younger than 25 years. This anticipa-
tion in the age at diagnosis was also found in the Italian
study by Malandrino and co-workers [20] involving pop-
ulations living in volcanic areas. As a matter of fact,
Neapolitan patients mainly came from the areas around the
volcano Vesuvius and Campi Flegrei, which are exposed to
volcanic minerals, according to ARPA data [25]. There-
fore, this phenomenon of age anticipation could be related
to the exposure to one or more volcanic carcinogens (in
particular heavy metals) [21–23, 32–36]. It has already
been reported that high heavy metal concentration in the
soil or water would act as endocrine disruptors, increasing
the risk for thyroid cancer in younger age because their
Fig. 3 Histotype variants of PTC in groups A and B
Fig. 4 Focality, laterality and thyroid capsular invasion in groups A
and B
Fig. 5 Staging in groups A and B
Fig. 6 Tumour-associated thyroiditis in groups A and B: trend over
the years
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effects may manifest in utero, in children and in adulthood
[37]. Moreover, considering only thyroid cancers larger
than 1.0 cm, in this group, we found a significantly higher
incidence of larger thyroid cancers, even papillary types,
according to other studies regarding populations living in
volcanic areas [21, 36]. In these areas, there seems to be a
significant inverse relationship between tumour size and
age at diagnosis (the mean tumour size was significantly
higher in younger patients in a Sicilian cohort around Etna
volcano) [38].
On the other hand, in Novara’s group, we found older
age at diagnosis, differently from what reported in litera-
ture [2, 11, 31]. It has to be considered that also Fugazzola
and co-workers (Abstract no. 20. Abstract book from 9
Congresso Associazione Italiana della Tiroide) recently
showed an increased age at diagnosis in their population
living in Milan and surrounding areas, close to Novara
region.
This increase in thyroid cancer incidence in elderly
population could be due to the combined effect of radia-
tions and natural changing of hormonal status in this age
[39, 40]. Therefore, considering that Northern Italy was
more exposed to Chernobyl’s nuclear radiations than
Southern Italy, as shown in the European map from Ch-
ernobyl, 22 years later, CBS News [41], we could speculate
that in Novara’s group, we are now observing the second
peak of tumours after about 20 years of latency.
Another interesting observation coming from our data
concerns the histopathological features. In Novara’s group,
we found a higher percentage of follicular variant of PTC
(FVPTC) compared to Neapolitan group and other Italian
cohorts [42]. The FVPTC is a heterogeneous disease that
includes two different groups of tumours: one similar to the
classical PTC in its behaviour and another more similar to
FTC in its invasive features and molecular profile [43].
Certainly, the re-classification of FVPTC in these 2 sub-
groups and the genetic characterization of tumours in our
population might be helpful to explain their higher inci-
dence in Novara’s group.
Furthermore, in Novara’s cohort, CDT showed more
histopathological aggressive features already at diagnosis,
such as thyroid capsular invasion, bilaterality and multi-
focality. The same was seen in microcarcinomas, espe-
cially with regard to bilaterality and multifocality, even if
in literature these two characteristics do not seem to
adversely affect survival [11]. This result corroborates the
data available in the literature [44] showing that micro-
scopic thyroid cancer at presentation can be as aggressive
as macroscopic disease, regardless of whether the tumour is
incidentally discovered or not. Molecular studies would be
able to differentiate, at an early stage, microcarcinomas
with an aggressive behaviour from microcarcinomas with
an indolent clinical course. The increased aggressiveness
could correlate with and another risk factor, of which
Novara’s population is exposed, chemical pollutants in
atmosphere [45, 46]. As a matter of fact, Novara is placed
in a predominantly industrial area and the population is
exposed to chemical pollutants such as formaldehyde and
benzene [24]. Most of the population came from the
Eastern part of the Novara province, where the industries
are predominantly placed, especially in the textile and
engineering fields; about 30.0 % of our patients were
employed in the textile sector and about 25.0 % in the
engineering industry. According to ARPA data collected
from 2003 to 2009 [24], environmental exposure to
formaldehyde and benzene in this area was recognized to
be higher than in the rest of Italy. The correlation between
thyroid cancer and exposure to formaldehyde and benzene
emerges in several studies reported in literature [47–49]. In
particular, a study conducted on a cohort of Chinese
women working in the textile industry in Shanghai showed
a strong association between thyroid cancer and exposure
to formaldehyde [47]. Even exposure to benzene has been
shown to be related to thyroid cancer, but with a lower
extent than formaldehyde. To date, few studies focused on
the role of these substances in thyroid cancer and on the
mechanisms of inducing tumourigenesis, but all agree with
the hypothesis that these chemicals can determine both the
tumour onset and its more aggressive behaviour [47–49].
We can speculate that in the Northern area both envi-
ronmental factors (radiation or chemical pollutants expo-
sure), together or alone might play a role in thyroid
tumourigenesis. From a recent review by Marcello and co-
workers [23], radiation exposure seems to be the cause of a
high percentage of RET/PTC rearrangements, while
chemical pollutants seem to be associated with BRAF
mutations, and more specifically BRAFV600E point muta-
tion. Thus, the study of the underlying biological and
molecular pathways in our population could help us to
understand which etiopathogenetic hypothesis is most
probable.
Finally, no significant difference was found in iodine
level, being median urinary iodine 87 lg/L in Naples [50]
and 98 lg/L in Piedmont [26], as both populations belong
to region with mild iodine deficiency. In both the groups,
we found a similar distribution of associated thyroiditis
with an increasing trend over time in term of both tumour-
associated inflammation and TPOAb positivity. This could
be explained by 2 hypothesis: 1) the increase in the iodine
intake [51] as a result of programmes of iodine prophy-
laxis [52]; 2) external factors (still unknown) probably
triggering both thyroid disorders, inflammation and
tumour [53]. However, if the increased frequency of
thyroiditis would be an additional factor contributing to
the continuous increase in incidence of thyroid cancer, it
is still debated [54, 55].
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The present study has some potential limitations. It was
retrospective and cases were collected from the Pathology
archives, so we cannot supply complete information about
the reasons of all the thyroid surgical interventions and
about the incidental nature of all microcarcinomas. More-
over, we do not have a control group, and thus, we com-
pared our data with others coming only from Italian
studies.
The role of these potential chemicals and environmental
factors in inducing thyroid cancer is only conceivable. A
greater number of studies are required to classify the role of
these substances, in order to accurately understand their
physiopathological mechanisms of induction of tumouri-
genesis and the clinical and histopathological characteris-
tics, they are responsible for.
Conclusions
The more sensitive and widespread diagnostic procedures
can only partially justify the progressive increase in DTC.
More studies are necessary to investigate the role of
environmental factors, which include both volcanic ele-
ments and industrial chemical pollutants.
In this scenario, a national cancer registry could be a
mirror of the different territories and could provide a better
understanding of the different risk factors and mechanisms
involved in tumourigenesis.
It could also allow to carry out comparative studies,
through which it would be possible to outline the charac-
teristics of the populations at risk and then to perform
screening programmes and prevention, improving the
management of DTC.
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